Product Name | MF | CAS | Details |
---|
Alantolactone | C15H20O2 | 546-43-0 | Details |
(1R,3S)-(3-Hydroxy-cyclohexyl)-carbamic acid tert-butyl ester | C11H21NO3 | 1403864-43-6 | Details |
TNF alpha protein | Details |
MAGOH Blocking Peptide | Details |
3-Bromo-5-hydrazinylpyridine | C5H6BrN3 | 801203-50-9 | Details |
2-(Dimethylamino)-2,3-dihydro-1H-indene-2-carboxylic acid hydrochloride | C12H16ClNO2 | 1333955-73-9 | Details |
1-[2,4-Dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]ethan-1-one | C13H16O3 | 19825-40-2 | Details |
4,4-Dimethoxybutan-1-ol | C6H14O3 | 23068-87-3 | Details |
Fosinoprilat acyl-b-D-glucuronide | C29H42NO11P | 113411-09-9 | Details |
seco erythromycin | C37H69NO14 | 143416-84-6 | Details |
2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-3'-C-methyluridine | C19H20N2O7 | 959843-61-9 | Details |
4-Iodo-1-(2-methoxyethyl)-1H-pyrazole-5-carboxylic acid | C7H9IN2O3 | 1354705-43-3 | Details |
Methyl 3-(5-amino-1,3,4-thiadiazol-2-yl)propanoate | C6 H9 N3 O2 S | 227958-72-7 | Details |
Cyanomethyl 3-sulfamoylbenzoate | C9H8N2O4S | 929972-75-8 | Details |
4,5-Dihydroxy-2H-chromen-2-one | C9H6O4 | 30992-74-6 | Details |
Lisinopril related compound A | C21H29N3O4 | 328385-86-0 | Details |
N6-Benzyladenine-3-glucoside | C18H21N5O5 | 56159-41-2 | Details |
Taxagifine | C37H44O13 | 81489-69-2 | Details |
Iristectorin A | C23H24O12 | 37744-61-9 | Details |
Dimethyl-4',4-oxybis(benzoate) | C16H14O5 | 14387-30-5 | Details |
8-Amino-6-(trifluoromethyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one | C9H7F3N2O2 | 459191-31-2 | Details |
5-Bromo-2-(4-methoxyphenoxy)pyrimidine | C11H9BrN2O2 | 69033-87-0 | Details |
PPP1CA protein (His tag) | Details |
(D-Lys6)-LHRH trifluoroacetate salt | C59H84N18O13 | 130751-49-4 | Details |
H-Gly-Phe-Ala-OH | C14H19N3O4 | 17123-30-7 | Details |
Bromo-PEG3-acid | C9H17BrO5 | 782475-35-8 | Details |
6,6,6-Trifluorohexan-3-one | C6H9F3O | 1194765-43-9 | Details |
PKA Substrate | C34H64N14O11 | 57836-10-9 | Details |
Ethyl 5-(2-chloroacetamido)-3-methylthiophene-2-carboxylate | C10H12ClNO3S | 285138-55-8 | Details |
3,4,4-Trimethyl-1-phenylpent-1-yn-3-ol | C14H18O | 85051-67-8 | Details |
DUS1L Blocking Peptide | Details |
4'-a-C-Methyladenosine | C11H15N5O4 | 152540-76-6 | Details |
1-Boc-7-hydroxy-1-azaspiro[4.4]nonane | C13H23NO3 | 1823268-34-3 | Details |
NDUFA10 antibody | Details |
2-Chloro-1-[2-(thiophen-3-yl)pyrrolidin-1-yl]ethan-1-one | C10H12ClNOS | 1179119-21-1 | Details |
N-[3-(Methylsulfanyl)propyl]pyridin-3-amine dihydrochloride | C9H15ClN2S | 2044796-57-6 | Details |
3-Methanesulfonylbenzene-1-sulfonamide | C7H9NO4S2 | 22821-83-6 | Details |
PCOLCE Blocking Peptide | Details |
1-[(Methylamino)methyl]cyclopropan-1-ol hydrochloride | C5H12ClNO | 1574118-06-1 | Details |
4',5-Di-o-methyl quercetin | C17H14O7 | 100648-56-4 | Details |
Methyl 1-boc-5-hydroxypiperidine-3-carboxylate | C12H21NO5 | 1095010-47-1 | Details |
(2S,4S)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}-4-phenoxypyrrolidine-2-carboxylic acid | C26H23NO5 | 1260617-48-8 | Details |
LRRFIP1 antibody | Details |
CANT1 Blocking Peptide | Details |
3-(2,4-Dichlorophenyl)-1,2-oxazol-5-amine | C9H6Cl2N2O | 501902-19-8 | Details |
MRTO4 antibody | Details |
3-(2-Aminoethyl)pyrrolidin-2-one hydrochloride | C6H13ClN2O | 1987266-33-0 | Details |
Dimethoxy-[1,3]thiazolo[4,5-d]pyrimidin-2-amine | C7H8N4O2S | 1526241-35-9 | Details |
ALKBH8 Blocking Peptide | Details |
EPHB2 antibody (Tyr317) | Details |
8H-Indeno[1,2-d][1,3]thiazol-2-amine hydrobromide | C10H9BrN2S | 115247-57-9 | Details |
5-Methylspiro[2.3]hexane-5-carboxylic acid | C8H12O2 | 1773508-76-1 | Details |
[(3-Methylphenyl)methyl](2-methylpropyl)amine | C12H19N | 1019606-15-5 | Details |
3-(4-Chloro-1H-pyrazol-1-yl)butanethioamide | C7H10ClN3S | 1006320-01-9 | Details |
1-(3-Bromophenyl)-3-methyl-1H-pyrazol-5-amine | C10H10BrN3 | 956329-14-9 | Details |
1-((4-(3-chloro-5-(trifluoromethyl)(2-pyridyl))piperazinyl)sulfonyl)-2-nitrobenzene | C16H14ClF3N4O4S | 946387-22-0 | Details |
2-Chloro-N-[4-methyl-3-(piperidine-1-sulfonyl)phenyl]acetamide | C14H19ClN2O3S | 438032-02-1 | Details |
PDGF AB protein | Details |
beta Lipotropin antibody | Details |
3',5'-Di-O-acetyl-2'-deoxyguanosine | C14H17N5O6 | 69992-10-5 | Details |
3-(4-Chlorophenyl)-1,1-dimethoxypropan-2-ol | C11H15ClO3 | 1487502-22-6 | Details |
(2E)-3-(8-Bromo-2,3-dihydro-1,4-benzodioxin-6-yl)prop-2-enoic acid | C11H9BrO4 | 1094225-83-8 | Details |
(2-Cyclopropyl-3-methyloxolan-3-yl)methanamine hydrochloride | C9H18ClNO | 1803583-84-7 | Details |
1-(4-Methoxyphenyl)pyrrolidin-3-ol | C11H15NO2 | 39104-01-3 | Details |
N-[(2,6-Difluorophenyl)methyl]cyclopentanamine | C12H15F2N | 1019629-72-1 | Details |
4-(4-(2-(trifluoromethyl)phenyl)-3-(E)-buten-2-one-1-yl)piperidine-2,6-dione | Details |
Propofol-D-glucuronide methyl ester | C19H28O7 | Details |
[1-(Methoxymethyl)cyclopent-2-en-1-yl]methanol | C8H14O2 | 2230804-24-5 | Details |
Sulbactam Related Compound D | C8H11BrKNO3S | 4027-64-9 | Details |
tert-Butyl 6-cyano-1,2,3,4-tetrahydroquinoline-1-carboxylate | C15H18N2O2 | 1820604-90-7 | Details |
2-(2-Aminopropoxy)acetic acid hydrochloride | 2361852-29-9 | Details |
2-(4-Methylcyclohexyl)ethan-1-amine hydrochloride | C9H20ClN | 102450-01-1 | Details |
4-?(2-?Bromoethyl)?-thiomorpholine 1,?1-?dioxide hydrobromide | C6H13Br2NO2S | 1803583-00-7 | Details |
3,4,5-Trifluoromandelic acid | C8H5F3O3 | 1214323-60-0 | Details |
SRF antibody (Ser99) | Details |
3-Amino-4-(ethylamino)benzamide | C9H13N3O | 1153120-26-3 | Details |
Eltrombopag Acyl Glucuronide | C31H30N4O10 | 1396009-05-4 | Details |
H-Trp-Val-OH | C16H21N3O3 | 24613-12-5 | Details |
Deacetylnimbinene | C26H32O6 | 912545-53-0 | Details |
4-[4-(Chloromethyl)-1,3-oxazol-2-yl]benzonitrile | C11H7ClN2O | 202594-69-2 | Details |
3-O-Benzyl estradiol | C25H30O2 | 14982-15-1 | Details |
3-(Cyclobutylidenemethyl)piperidine hydrochloride | C10H18ClN | 1803571-46-1 | Details |
N-[4-(2-Amino-thiazol-4-yl)-phenyl]-4-chloro-benzenesulfonamide | C15H12ClN3O2S2 | 438030-35-4 | Details |
1-(3,5-Dichlorophenyl)-2-phenylethan-1-amine hydrochloride | C14H14Cl3N | 1279852-41-3 | Details |
4-Bromo-1-(difluoromethyl)-2-nitrobenzene | C7H4BrF2NO2 | 1261442-15-2 | Details |
4-Methoxypyrimidine-2-carboxamide | C6H7N3O2 | 1909327-26-9 | Details |
ITLN2 Blocking Peptide | Details |
Ethyl 4-(2,6-dichloro-3-fluorophenyl)-2,4-dioxobutanoate | C12H9Cl2FO4 | 1041553-00-7 | Details |
2,2-Dimethyl-4-nitro-3-phenylbutanal | C12H15NO3 | 93086-29-4 | Details |
Methyl 2-methylmorpholine-2-carboxylate hydrochloride | C7H14ClNO3 | 1205750-77-1 | Details |
N-(4-Fluorophenyl)-4-[(methylamino)methyl]piperidine-1-carboxamide hydrochloride | C14H21ClFN3O | 1423033-82-2 | Details |
1-(Propan-2-yl)piperidine-2-carboxylic acid hydrochloride | C9H18ClNO2 | 1306602-99-2 | Details |
4-Nitrophenyl 2,6-di-O-benzoyl-a-D-galactopyranoside | C26H23NO10 | 135216-30-7 | Details |
3-(Difluoromethyl)morpholine hydrochloride | C5H10ClF2NO | 2375261-03-1 | Details |
Sodium 2-(2-hydroxyethoxy)ethane-1-sulfonate | C4H11NaO5S | 53211-00-0 | Details |
1-Benzyl-1H-indole-2-carboxylic acid | C16H13NO2 | 17017-71-9 | Details |
[(1-Ethylpiperidin-3-yl)methyl]amine | C8H18N2 | 102459-02-9 | Details |
ADRB2 antibody | Details |
4-Nitrophenyl 4,6-benzylidene-3-O-(2,3,4,6-tetra-O-[4-methoxybenzyl]-a-D-glucopyranosyl)-a-D-glucopyranoside | Details |
Product Total: Product Page: | ||||
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |